Dow, S&P 500 hit fresh intraday records as stock market extends climb to fresh peaks

U.S. stocks on Tuesday opened slightly higher as equity benchmarks extended a multisession rise powered by hope of a more favorable tax regime and an upbeat outlook for coming corporate results. The Dow Jones Industrial Average opened up 32 points, or 0.1%, at 22,591, the S&P 500 index climbed 2 points, or 0.1%, at 2,531, while the Nasdaq Composite Index gained 9 points, or 0.1%, at 6,525. The S&P 500 and the Dow hit opening intraday records early in the session, with the Nasdaq not far behind. All three major stock gauges finished at all-time highs on Monday, as well as the small-cap oriented Russell 2000 Index , shaking off the grimness of a Sunday massacre in Las Vegas that left 59 people dead and scores more injured. In corporate news, shares of gun makers were still in focus, after Sunday’s mass shooting, with Smith & Wesson-parent American Outdoor Brands Corp. trading higher after strong gains on Monday. Meanwhile, shares of home builder Lennar Corp. were climbing after better-than-expected corporate results.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Chicken Soup for the Soul swings to loss in quarter before IPO

Shares of Chicken Soup for the Soul Entertainment Inc. ran up 2.7% in premarket trade Tuesday, after the provider of entertaining video content reported results for the quarter that ended just before the company went public. For the quarter to June 30, the company reported a net loss of $698,786, or 8 cents a share, after a profit of $53,218, or a penny a share, in the same period a year ago. Revenue fell 31% to $792,717 from $1,154,545, as TV revenue dropped 37% and online revenue slipped 3.7%. The company affirmed its 2017 revenue target of $20 million and 2018 target of $36 million. “This filing does not give effect to the company’s August IPO and its positive impact on the company’s financial strength,” said Chief Executive William Rouhana, Jr. The company went public on Aug. 18, when the stock closed at $9.25, or 23% below its IPO price of $12. The stock has lost 21% since then, while the S&P 500 has gained 4.3%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Analyst lowers CBS earnings estimates, but sees buying opportunity

Analysts at Evercore lowered estimates slightly for CBS Corp. full-year earnings for 2017 and 2018. Evercore analysts, led by Vijay Jayant, maintain an outperform rating and $75 12-month price target on CBS, but lowered 2017 earnings estimates to $4.44 from $4.47. Jayant also lowered 2018 estimates to $5.17 from $5.18. CBS shares, down nearly 9% in the last three months, have among the lowest valuation of the media sector, but at current levels, Jayant sees a buying opportunity heading into 2018. In his view, CBS is insulated from cord cutting, fears of which have continued to impact media companies’ stocks. “The company’s proprietary [over-the-top] services hedge against changes in pay-TV distribution,” Jayant wrote in a note to investors. “Further, we understand that CBS has been commanding better rates from most virtual [multichannel video programming distributor] platform operators compared with pricing within the traditional ecosystem.” Jayant also wrote that CBS’s underlying advertising fundamentals appears solid, despite recent ratings softness. Shares of CBS are down 8% in the year to date, while the S&P 500 index is up 13% and the Dow Jones Industrial Average is up more than 14%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Tile Shop shares plummet after sales warning

Tile Shop Holdings Inc. shares plummeted 33% in Tuesday premarket trading after the specialty retailer issued a sales warning for the third quarter. Tile Shop said after-hours Monday that it expects sales of $84.0 million, up from $78.6 million last year, but below the $86.6 million FactSet consensus. Same-store sales are expected to rise 1%, below the FactSet estimate for a 2.2% increase. In addition to a competitive environment, Chief Executive Chris Homeister said the miss was due to heightened demand for “opening price point offerings,” which drove increased promotions and advertising. The company is introducing new items to meet the demand, Homeister said in a statement, and adjusting its promotions approach. Tile Shop will announce full third-quarter results on September 30. Tile Shop shares are down 32.5% for the year so far while the S&P 500 index is up 13% and the Dow Jones Industrial Average {s: djia] is up 14.1% for the period.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Optinose to sell 6.25 million shares at $15 to $17 a pop in IPO

Specialty pharma company Optinose on Tuesday outlined the terms of its planned initial public offering. The company, which specializes in products for ear, nose and throat and allergies, said it plans to sell 6.25 million shares priced at $15 to $17 each. Jefferies, Piper Jaffray, BMO Capital Markets and RBC Capital Markets are underwriters on the deal. The company is planning to list on the Nasdaq under the ticker symbol “OPTN.” The company is planning to use the proceeds of the IPO to suppor the launch of Xhance for the treatment of chronic sinusitis, for working captial and general corporate purposes.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Wal-Mart acquires New York City delivery service Parcel

Wal-Mart Stores Inc. said Tuesday that it has acquired Parcel, a New York City-based delivery service that specializes in bringing customers goods across the “last mile.” Parcel delivers same-day, overnight and in scheduled two-hour windows. Wal-Mart plans to leverage the Parcel purchase to deliver to New York City customers, including same-day, and fresh and frozen groceries from Walmart and Jet.com. Parcel will also continue to service its current clients. The company has partnerships with a number of meal kit, grocery and e-commerce companies. The financial details of the acquisition weren’t disclosed, but Wal-Mart said the deal “was smaller than previous acquisitions we’ve made this year.” Among those acquisitions were women’s clothing company ModCloth and menswear company Bonobos, which was bought for $310 million. Wal-Mart recently announced that it is testing a program with August Home to deliver in a customer’s home, including in their refrigerator. Wal-Mart shares are down 0.2% in premarket trading, and are up 13.5% for the year so far. The S&P 500 index is up 13% for 2017 to date and the Dow Jones Industrial Average is up 14.1% for the period.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Tesla upgrades its FY17 delivery outlook; Baird analyst advises ‘aggressive’ buying

Tesla, Inc. on Monday said it delivered 26,150 vehicles in the third quarter and raised its full-year outlook to 100,000 vehicles. That would represent a 31% yearly increase for deliveries and would mitigate lingering uncertainty about the company’s ability to overcome production glitches. “Production should continue to ramp and we believe Model S and X demand remains strong,” wrote Ben Kallo, a senior research analyst at Baird in a Tuesday note. “We would be aggressive buyers on any weakness.” Kallo noted strong demand for Tesla’s products, upcoming new product launches including a Semi Truck, and announcements about new technologies such as Tesla Energy. Shares in the company have gained 60% in the year-to-date, compared to a 13% gain for the S&P 500 .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Buffett’s Berkshire buys 38.6% stake in travel center operator Pilot Flying J

Warren Buffett’s investment vehicle Berkshire Hathaway Inc. said Tuesday it is buying a 38.6% stake in Pilot Travel Centers LLC, which does business as Pilot Flying J, a family-owned operator of travel centers in North America. The Haslam family will continue to own a majority stake in the company, which has more than $20 billion in revenues, more than 27,000 employees and 750 locations across the U.S. and Canada, Berkshire said in a statement. Jimmy Haslam will remain as chief executive, and the management team will remain in place. The company will remain headquartered in Knoxville, TN. The Maggelet family will retain its 11.3% ownership. In 2023, Berkshire will buy an additional 41.4% equity stake and become majority shareholder, leaving the Haslam family with a 20% stake. Buffett also owns stakes in a number of U.S. airlines, including American Airlines Group Inc. , Delta Air Lines Inc. , Southwest Airlines Co. and United Continental Holdings Inc. . Berkshire class B shares were slightly higher premarket, and have gained 14% in 2017, while the S&P 500 has gained 13%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Rigel shares soar 14% on positive data in early study of treatment for rare form of anemia

Rigel Pharmaceuticals Inc. said Tuesday a phase 2 study of a treatment for patients with warm antibody autoimmune hemolytic anemia, or AIHA, met its main goal in stage 1 of the trial, sending its stock up 14% premarket. The company said the two-stage study of fostamatinib met the pre-specified primary efficacy endpoint, which was defined as achieving a hemoglobin level of greater than 10 grams per decileter of blood and at least a 2 g/dl increase from baseline. The study aims to evaulate the safety and efficacy of fostamatinib in patients with the disease who have received at least one treatment but still suffer from anemia. There is no available treatment for warm antibody AIHA, which affects about 40,000 adults in the U.S. The disease is a rare, serious blood disorder, in which the immune system creates antibodies that destroy the body’s own red blood cells. Rigel shares have gained 42% in 2017, while the S&P 500 has gained 13%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Allergan’s Botox gets FDA OK to treat forehead lines

Allergan PLC said Tuesday that the Food and Drug Administration has approved Botox for the temporary improvement of moderate-to-severe forehead lines. Botox is already approved for treat “crow’s feet” and glabellar lines. Allergan’s stock, which was still inactive in premarket trade, has tumbled 13.5% over the past three months, to be up just 0.5% year to date, while the S&P 500 has gained 4.1% over the past three months and 13.0% this year.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News